DOVETeam.jpg
DOVE_edited_edited.png

DOVELabs

DOVEDevice_ArmBand.jpg

DOVE

Saving lives one injection at a time

The DOVE device is an auto-injector that can detect an overdose as it occurs and inject naloxone in a timely manner to reverse the fatal overdose.It will be capable of preventing the overdose deaths that occur when patients are alone. This will also help save insurers and governments from hospitalization costs of overdoses where naloxone is not administered in time.

DOVE was originally developed in the Brenner Bioengineering Lab, and is now part of an academic collaboration including Penn and Drexel University.  Our goal is to develop DOVE and other technologies to address the intersection of medicine and social justice.

Naloxone is an effective overdose antidote if a bystander administers it
>81,000
US Opioid Overdose Deaths

Jun 2019 - June 2020

>52%
Fatal Overdoses Occur Alone

Meet The Team

Headshot_JakeBrenner_DataBackground_2018-10-13.jpg

Jake Brenner

MD, PhD

1J8A6917 2.jpg

Anush Lingamoorthy

Ph.D. Student, Drexel Electrical Engineering

DOVE_edited.jpg

David Gordon

Medical Student, Thomas Jefferson University

DOVE_edited.jpg

Julia Gasior

Medical Student, University of Pennsylvania

DOVE_edited.jpg

Katie Kanter

Medical Student, University of Pennsylvania

DOVE_edited.jpg

Khang Lam

Master student, Drexel BioMedical Engineering

EthanPhoto.png

Ethan Donlon

Master Student, UPenn Mechanical Engineering

Emma_Ma_Headshot_2021-05-04.jpeg

Emma Ma

Research Specialist, University of Pennsylvania

DOVE_edited.jpg

Ayan Mandal

Medical Student, University of Pennsylvania

DOVE_edited.jpg

Korey Henderson

Medical Student, University of Pennsylvania

DOVE_edited.jpg

Sope Eweje

Medical Student, University of Pennsylvania

Alex Lee, med student.jpeg

Alex Lee

Medical Student, University of Pennsylvania